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Abstract Rieske proteins and Rieske ferredoxins are
present in the three domains of life and are involved in a
variety of cellular processes. Despite their functional
diversity, these small Fe–S proteins contain a highly con-
served all-b fold, which harbors a [2Fe–2S] Rieske center.
We have identified a novel subtype of Rieske ferredoxins
present in hyperthermophilic archaea, in which a two-
cysteine conserved SKTPCX(2–3)C motif is found at the
C-terminus. We establish that in the Acidianus ambivalens
representative, Rieske ferredoxin 2 (RFd2), these cysteines
form a novel disulfide bond within the Rieske fold, which
can be selectively broken under mild reducing conditions
insufficient to reduce the [2Fe–2S] cluster or affect the
secondary structure of the protein, as shown by visible
circular dichroism, absorption, and attenuated total reflec-
tion Fourier transform IR spectroscopies. RFd2 presents all
the EPR, visible absorption, and visible circular dichroism
spectroscopic features of the [2Fe–2S] Rieske center. The
cluster has a redox potential of ?48 mV (25 C and pH 7)
and a pKa of 10.1 ± 0.2. These shift to ?77 mV and
8.9 ± 0.3, respectively, upon reduction of the disulfide.
RFd2 has a melting temperature near the boiling point of
water (Tm = 99 C, pH 7.0), but it becomes destabilized
upon disulfide reduction (DTm = -9 C, DCm = -0.7 M
guanidinium hydrochloride). This example illustrates how
the incorporation of an additional structural element such
as a disulfide bond in a highly conserved fold such as that
of the Rieske domain may fine-tune the protein for a
particular function or for increased stability.
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Abbreviations
ANS 8-Anilino-1-naphthalenesulfonic acid
ATR FT-IR Attenuated total reflection Fourier transform
infrared
CD Circular dichroism
DTNB 5,50-Dithiobis(2-nitrobenzoic acid)
GuHCl Guanidinium hydrochloride
RFd2 Rieske ferredoxin 2
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel
electrophoresis
TCEP Tris(2-carboxyethyl)phosphine hydrochloride
TPTZ 2,4,6-Tripyridyl-s-triazine
Tris–HCl Tris(hydroxymethyl)aminomethane
hydrochloride
Introduction
Fe–S proteins are ubiquitous in all life domains and are
involved in many fundamental cellular processes, from
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electron transfer, to catalysis, to regulation of gene expres-
sion. The simpler Fe–S proteins, despite their low structural
complexity and small size (fewer than 150 amino acids), are
able to harbor clusters with different nuclearities ([2Fe–2S],
[3Fe–4S], [4Fe–4S]), or even combinations of clusters, as
in the dicluster ferredoxins ([3Fe–4S][4Fe–4S] and [4Fe–
4S][4Fe–4S]). In these proteins the inorganic moieties are
generally found in a single domain, having rather conserved
topologies [1]. The protein fold and the Fe–S clusters have
an intertwined contribution to the structural stability of these
proteins: whereas polypeptide scaffolding provides a rela-
tively rigid and protective ligand environment for cluster
binding, the chemical stability of the Fe–S cluster itself has a
key stabilizing effect on the structure.
The conserved folds of simple Fe–S proteins are in some
cases decorated by additional structural elements that
somehow broaden and shape the structural and functional
landscape of these proteins. Examples include N- and
C-terminal amino acid extensions within dicluster ferre-
doxins [2, 3], insertion of a structural zinc site [4], and
incorporation of a disulfide bond within the fold [5–7]. For
instance, dicluster [3Fe–4S][4Fe–4S] ferredoxins [3] con-
tain an N-terminal extension, which modulates the protein
stability either by hosting an additional His/Asp zinc center
[4, 8] or by creating a stabilizing hydrophobic core [9].
Also, a disulfide bond has been shown to contribute sig-
nificantly to the stability of the [2Fe–2S] plant-type ferre-
doxin from the hyperthermophilic bacterium Aquifex
aeolicus, as its presence increases the melting temperature
from 113 to 121 C [6]. One last example is given from the
respiratory-type Rieske proteins, in which a strictly con-
served disulfide in the immediate vicinity of the [2Fe–2S]
cluster (within 5 A˚) stabilizes the cluster binding loops and
modulates the redox potential [10].
In this context, Rieske proteins are interesting examples
of the functional and structural diversity within a family of
proteins that share the same basic all-b fold [1, 11]. These
proteins have the distinct feature of harboring a [2Fe–2S]
cluster coordinated by two cysteine and two histidine resi-
dues. Like in other Fe–S proteins, a considerable diversity is
allowed at the level of the primary structure without dis-
turbing the structural topology, whereas the type of amino
acid side chains and the electrostatic environment found
around the [2Fe–2S] Rieske cluster modulate the redox
potential of the center. This results in a broad range of
functional potentials, from around -150 mV for the soluble
Rieske ferredoxins from the dioxygenase components [12],
to up to ?400 mV for the photosynthetic or respiratory
Rieske domains [13, 14]. Subsequent to a thorough phylo-
genetic analysis [11, 15], the diversity of Rieske proteins
was considerably expanded, in particular, concerning the
soluble Rieske-type ferredoxins, as many novel sequences
were identified mostly within phyletically distant organisms
from the Archaea domain. Subsequent analysis using com-
plete genome data has allowed the establishment of the
existence of evolutionarily related sequences within
Thermoprotei, an archaeal class comprising hyperthermo-
acidophilic organisms belonging to the Sulfolobus and
Caldisphaera genera [16]. The genes identified encode for
proteins with the typical Rieske fingerprint, but with very
little amino acid identity toward other Rieske proteins. Here
we report a novel structural feature within the all-b Rieske
fold, which was identified upon studying one of these as-yet
uncharacterized archaeal Rieske ferredoxins from Acidi-
anus ambivalens (EMBL FN557298). It consists of a
disulfide bond within the Rieske fold, whose redox status
influences the properties of the [2Fe–2S] center and simul-
taneously stabilizes the protein. This particular disulfide is a
novel feature within Rieske proteins, and is unrelated to the
disulfides described in respiratory and photosynthetic
Rieske domains [17] and in the archaeal respiratory-type
SoxF [5] and sulredoxin [18] proteins, which have distinct
locations in the fold. This finding illustrates how minor
structural modifications modulate protein function and sta-
bility and is key to rationalizing the evolutionary adapation
of simple Fe–S proteins to distinct conditions and to
understanding how relatively simple folds may be fine-
tuned for a particular function or for increased stability.
Materials and methods
Sequence comparison
Homologous Rieske amino acid sequences were extracted
from the nonredundant protein database using BLAST and
A. ambivalens Rieske ferredoxin 1 (Genbank 22204177)
and Rieske ferredoxin 2 (RFd2), Sulfolobus tokodaii sul-
redoxin, and S. solfataricus archaeal Rieske ferredoxins as
seeds. All organisms were included in the search. We
considered the hits with E values of less than 10-10 to be
significant. Sequences were aligned using ClustalX
[19], MAFFT (http://align.bmr.kyushu-u.ac.jp/mafft/online/
server/) [20], GeneDoc [21], and CINEMA (http://www.
bioinf.manchester.ac.uk/dbbrowser/CINEMA2.1/) [22].
Dendrograms were calculated using the MAFFT server and
displayed using PhyloWidget (http://www.phylowidget.
org/). The nucleotide sequence of the rfd2 gene was sub-
mitted to the EMBL database and was assigned the
accession number FN557298.
Chemicals
All reagents were of the highest grade available commer-
cially. Guanidinium hydrochloride (GuHCl) was obtained
from Promega and the accurate concentration of its
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solutions was determined by refractive index measure-
ments. 8-Anilino-1-naphthalenesulfonic acid (ANS), tris(2-
carboxyethyl)phosphine hydrochloride (TCEP), and 5,50-
dithiobis(2-nitrobenzoic acid) (DTNB) were purchased
from Sigma.
Cloning, expression, and purification
Acidianus ambivalens DSMZ 3772 was grown aerobically
and anaerobically according to published procedures [23].
The gene encoding RFd2 was PCR-amplified from
A. ambivalens genomic DNA using the following N-terminal
and C-terminal primers: TATTT CATGA TTAAG ACAAT
TCTTT ATGAA and AAACA ACTCG AGTGT ACCTT
TTCTA GGTAA TTC, respectively. The N-terminal primer
swapped the native presumable GTG start codon for an
ATG. The 336-bp PCR product was digested with BspHI
and XhoI and ligated into the NcoI/XhoI-digested vector
pET28a (Novagen, now Merck Biosciences, Darmstadt,
Germany), thus adding two amino acid codons for the XhoI
restriction site and a C-terminal His-tag to the native protein
(…LEHHHHHH). The protein was produced after isopro-
pyl b-D-thiogalactopyranoside induction at an optical den-
sity of 0.6–1 in Escherichia coli BL21 CodonPlus RIL DE3
cells (Stratagene, now Agilent Technologies) grown over-
night at 37 C in Luria–Bertani medium supplemented with
1 9 10-3 vol of a 100 mM ferric chloride in 100 mM citric
acid solution. E. coli cells (40 g) were resuspended after
harvesting in 400 ml of 40 mM potassium phosphate buffer
pH 8 containing 300 mM NaCl and 10 mM imidazole. The
cells were broken using a continuous French press (Con-
stant Systems, Daventry, UK) followed by two centrifuga-
tion steps (15 min at 15,000g and 60 min at 150,000g,
respectively). Two hundred milliliters of the clear super-
natant was applied to a 20-ml nickel nitrilotriacetic acid
column (Qiagen, Hilden, Germany) equilibrated with the
same buffer and connected to a fast protein liquid chro-
matography instrument (Pharmacia, now GE Health Care,
Freiburg, Germany). The column was washed with 3 vol of
50 mM imidazole and finally the contents were eluted with
500 mM imidazole, both in the same buffer. The colored
fractions were combined and dialyzed against 40 mM
phosphate buffer pH 8. The sample was subsequently dia-
lyzed against 70 mM tris(hydroxymethyl)aminomethane
hydrochloride (Tris–HCl) pH 7.7, 150 mM NaCl and
loaded onto a calibrated Sephadex G-50 column
(2 cm 9 50 cm) previously equilibrated with the same
buffer. Rieske ferredoxin was eluted as a pure sample as
verified by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) [24] and the typical UV/vis
absorption spectrum. This pink stock solution was con-
centrated to around 1–2 mg/ml by ultrafiltration using a
5-kDa-cutoff membrane (Amicon Ultra, Millipore), flash-
frozen at liquid nitrogen temperature, and stored at -20 C
for subsequent studies. Protein was quantified using
Bradford’s method [25].
Disulfide reduction
The Rieske ferredoxin was purified in the oxidized state.
Full reduction was achieved with excess ascorbate or
sodium dithionite at room temperature. Spectra were
obtained with 4.6 lM (0.06 mg/ml) [far-UV circular
dichroism (CD)] or 15.2 lM (0.2 mg/ml) (near-UV/vis CD
and absorption) protein in 2 mM potassium phosphate pH
7. Low buffer concentrations are required to minimize
absorption in the far-UV region. Other reduced Rieske
samples were obtained by incubating 7.6 lM protein with
5 mM dithiothreitol or 5 mM TCEP for 1 h in 50 mM
potassium phosphate pH 7 at room temperature.
Spectroscopic methods
UV/vis spectra were recorded with a Shimadzu UVPC-
1700 spectrometer equipped with cell stirring and a Julabo
water-bath-coupled thermostated cell support. Unless
otherwise indicated, UV/vis absorption spectra were
recorded at room temperature. CD measurements were
performed using a JASCO J-815 spectrometer and fluo-
rescence data were acquired with a Cary Varian Eclipse
instrument, both possessing Peltier-thermostated cell sup-
ports. Attenuated total reflection Fourier transform infrared
(ATR FT-IR) spectra were acquired with a Bruker IFS 66/S
spectrometer equipped with a nitrogen-cooled mercury
cadmium telluride detector using a water-thermostatized
Harrick BioATRcell II cell. EPR spectra were acquired
using a Bruker EMX spectrometer equipped with an ESR
900 continuous-flow helium cryostat at -263 C, 9.39-
GHz microwave frequency, 2.4-mW microwave power,
and 1-mT modulation amplitude.
Conformational stability
The conformational stability of Rieske ferredoxin was
assessed by performing temperature- or chemical-induced
denaturation while following several spectroscopic proper-
ties: (1) visible absorption, which reports on the [2Fe–2S]
cluster integrity; (2) tyrosine fluorescence, which reports on
tertiary contacts; and (3) ANS fluorescence, which reports on
the exposure of hydrophobic patches. Protein was prepared
at 7.6 lM concentration in 50 mM potassium phosphate pH
7. Data treatment was performed as described in [26].
For thermal-induced denaturation, we incubated the
Rieske ferredoxin with no reductant, 5 mM TCEP, or
5 mM dithiothreitol plus 0 or 2.5 M GuHCl at 25 C.
Then, we performed 1 C/min temperature ramps (25–
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92 C) while measuring the UV/vis absorption spectrum or
tyrosine fluorescence at 304 nm. The fluorimeter was set
up for excitation at 275 nm using 10-nm excitation and
emission slits and 600-V photomultiplier tube voltage.
Refolding was assessed by equilibrating the sample at 4 C
overnight (absorption) or at 25C for 5 min (fluorescence).
GuHCl-induced chemical denaturation curves were
obtained by incubating the Rieske ferredoxin with 0 or
5 mM TCEP and different concentrations of GuHCl for at
least 3 h at room temperature. The denaturation curve
corresponds to the normalized variation of fluorescence
intensity at 304 nm or absorbance at 330 nm. The chemical
denaturation was further dissected by incubating the same
samples with tenfold molar excess of ANS for at least
30 min at room temperature. In this case, the folding status
was probed by the ANS emission band (kexc = 350 nm).
ATR FT-IR spectroscopy
For ATR FT-IR spectroscopy, the Rieske ferredoxin was
concentrated by ultrafiltration to 0.8 mM (10.5 mg/ml) in
40 mM Tris–HCl pH 7 and then centrifuged for 30 min at
12,000g to remove aggregates. Spectra were acquired at
20 C and 4-cm-1 resolution with 0 or 5 mM TCEP after
3-h equilibration. The amide I band was deconvoluted by
fitting its Fourier self-deconvolution with Lorentzian
curves centered at the second-derivative maxima and
minima. Band assignment was performed using the refer-
ence data in [27]. The secondary structure was estimated
by the Lorentzian integrals.
Redox potentiometry
The reduction potential of the [2Fe–2S] Rieske cluster was
determined at 20 C and with 7.6 lM protein in 50 mM
potassium phosphate pH 7 with and without 5 mM TCEP.
The redox state of the Rieske [2Fe–2S] cluster was probed
by the absorbance change at 490 nm. The following redox
mediators were used: 1,2-naphthoquinone-4-sulfonic acid
(?215 mV, 0.6 lM), 1,2-naphthoquinone (?180 mV,
0.6 lM), trimethylhydroquinone (?115 mV, 0.6 lM),
phenazine methosulfate (?80 mV, 0.6 lM), 1,4-naphtho-
quinone (?60 mV, 0.6 lM), 5-hydroxy-1,4-naphthoquinone
(?30 mV, 0.6 lM), methylene blue (?11 mV, 0.79 lM),
menadione (0 mV, 0.6 lM), indigo tetrasulfonate
(-30 mV, 0.4 lM), indigo trisulfonate (-70 mV, 0.55 lM),
2,5-hydroxy-p-benzoquinone (-130 mV, 0.23 lM), and
2-hydroxy-1,4-naphthoquinone (-152 mV, 0.4 lM); all
potentials are with respect to the standard hydrogen elec-
trode. Additionally, catalase (0.002 mg/ml), glucose oxi-
dase (1.6 U/ml), and glucose (0.86 mM) were added to
ensure O2-free conditions. The fully oxidized protein was
titrated anaerobically with buffered sodium dithionite. The
sample with 5 mM TCEP was incubated for 3 h at room
temperature, after which time the [2Fe–2S] center had been
reduced. The oxidized center was regenerated by bubbling
with air. UV/vis absorption spectra were recorded during the
spontaneous re-reduction of the cluster. Several oxidation–
reduction cycles were performed and the reduction behavior
did not change, despite the progressively lower re-reduction
rates (approximately 20–35 mV/min) due to reductant oxi-
dation by oxygen. The titration curve includes data points
from several reduction cycles. The midpoint reduction
potential was determined by fitting a Nernst curve (n = 0.7,
0 mM TCEP; n = 1, 5 mM TCEP) to the normalized var-
iation of absorption at 490 nm. The lower than unity value
for the n value for a one-electron-acceptor center is within
the experimental uncertainty and likely reflects a slight off-
equilibrium in that set of measurements since the visible
absorption spectra of both samples are identical (Fig. S4).
pH titration
The pKa of the Rieske cluster was determined by investi-
gating the pH-associated changes of the visible CD spec-
trum. Protein samples (11.4 lM ) were prepared in a buffer
solution composed of 2-morpholinoethanesulfonic acid,
N-(2-hydroxyethyl)piperazine-N0-ethanesulfonic acid, tri-
cine, taurine, N-cyclohexyl-3-aminopropanesulfonic acid
(each 10 mM) and 50 mM NaCl with and without 5 mM
TCEP poised at different pH values. The samples were
equilibrated overnight at room temperature before mea-
surement of the near-UV/vis CD spectrum at 25 C. One
pKa was determined by fitting the Hendersson–Hasselbalch
formalism to the average normalized CD variation at 338,
378, 417, 434, and 485 nm (0 mM TCEP sample) or 338,
378, 462, and 485 nm (5 mM TCEP sample).
Iron quantification
Fe2? was quantitated in Rieske ferredoxin samples using
the chromogenic ferrous iron chelator 2,4,6-tripyridyl-s-
triazine (TPTZ) using a protocol adapted from [28].
Briefly, iron was released from Rieske ferredoxin by deg-
radation in 0.9 M HCl. The protein fraction was removed
by precipitation in 8% trichloroacetic acid. The remaining
iron solution was buffered in 16% ammonium acetate and
reduced with 0.9% hydroxylamine hydrochloride. The
Fe2? concentration was then determined by the rise in the
absorbance at 593 nm upon adding 320 lM TPTZ using a
calibration with iron standards.
Thiol quantification
Four Rieske samples were prepared in 100 mM potassium
phosphate pH 8: oxidized native, 5 mM TCEP reduced,
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denatured in 6 M GuHCl plus 2 mM EDTA, and denatured
in 6 M GuHCl, 2 mM EDTA, and 5 mM TCEP. Protein
concentrations ranged from 23 to 69 lM and samples were
incubated between 60 and 90 min. After incubation, TCEP-
containing samples were desalted (HiTrap Desalting, GE
Healthcare) in argon-saturated 100 mM potassium phos-
phate pH 8, 50 mM NaCl buffer. Then, the thiol content was
determined by adding 2 mM DTNB and recording the
quantitative formation of TNB2- (e412 = 14,150 M
-1
cm-1). All procedures were carried at room temperature.
Results and discussion
RFd2 is a representative of a subtype of Rieske
ferredoxins
The protein used in this study, RFd2, was identified from a
search of the A. ambivalens genomic data (A. Kletzin, S.C.
Schuster, J. Eck, P. Palm, D. Oesterheldt, unpublished
work) using Rieske protein sequences as seeds. Among the
hits was also the previously characterized Rieske ferre-
doxin 1 [16]. The native RFd2 is a 106 amino acid protein
with a theoretical mass of 12,053 Da, and an isoelectric
point of 8.9, whereas the length of the recombinant protein
is 114 amino acids, including the His-tag (13,118 Da,
pI = 8.6). Subsequent database analysis using BLAST
allowed the identification of eight significant hits
(E B 10-17) related to RFd2, all from unannotated hypo-
thetical proteins from the Sulfolobales and Caldisphaerales
orders within the archaeal class Thermoprotei, which
comprises hyperthermophilic organisms. Sequence align-
ment (Fig. 1) and phylogenetic analysis suggest that the
latter cluster is a novel subgroup within the Rieske family
(Figs. S1, S2). This group has two prominent features: one
is an N-terminal truncation in a stretch which should
include the b1 strand of the Rieske fold, and the other is
the presence of an additional cysteine pair in an
SKTPCX(2–3)C motif at the C-terminal segment (Fig. 1), in
a position that maps into a loop region in the dioxygenase-
type Rieske structures [12, 29]. The sequence conservation
and close proximity of these additional cysteines is
Fig. 1 Multiple sequence alignment of Rieske ferredoxins and
ferredoxin domains. Lines with C–C denote the Rieske ferredoxin 2
disulfide bridge and the hypothetical disulfide bridge in the
sulredoxins. The latter is homologous to the disulfide from Rieske
proteins from membrane-bound electron transport proteins (bc1 and
b6f complexes). Numbers with species names denote the GenBank
accession numbers. RFds Rieske ferredoxins, RFd2 Rieske ferredoxin
2, ARF archaeal Rieske ferredoxin
J Biol Inorg Chem (2010) 15:271–281 275
123
suggestive of a structural role, which may involve forma-
tion of a disulfide bond or coordination of an additional
metal ion, such as zinc. The rfd2 gene was cloned and
expressed in E. coli and the protein was purified to
homogeneity using chromatographic methods. The result-
ing pink protein was eluted as a monomer by gel filtration
chromatography and migrated in 15% SDS-PAGE gels as
being of size 14.7 kDa (Fig. S3). Iron quantitation using
the TPTZ methods determined 2.4 ± 0.1 (n = 3) iron ions
per molecule, which is compatible with the presence of an
intact [2Fe–2S] cluster in the purified protein.
Spectroscopic characterization of the Fe–S cluster
in RFd2
The presence of a [2Fe–2S] Rieske cluster was clearly
confirmed by subsequent biophysical analysis using UV/vis
absorption, visible CD, and EPR spectroscopies. The
identity of the Rieske [2Fe–2S] center was unambiguously
revealed by its characteristic EPR spectrum in the reduced
form. It consists of a rhombic signal characterized by g
values of gx = 1.80, gy = 1.90, and gz = 2.01 (Fig. 2a).
The average g value is 1.905, typical for [2Fe–2S] clusters
containing nitrogen ligands and significantly lower than the
value around 1.96 for plant-type [2Fe–2S] clusters. As
expected for an integer-spin system, no signal was
observed in the as-prepared, oxidized protein. The UV/vis
absorption spectrum exhibits characteristic bands at 337,
456, and 570 nm, and a shoulder at 490 nm (Fig. 2b). The
CD spectrum in the visible region has positive peaks at 418
and 483 nm and negative peaks at 379, 436, 528, and
569 nm (Fig. 2c). Altogether, the features observed by
these two techniques are typical of Rieske clusters [17].
The Rieske center is readily reduced by dithionite (Fig. 2b,
c; dotted lines) and partly reduced by ascorbate (Fig. 2b, c;
dashed lines), indicating that the redox potential of the
center has a positive value (see later).
The cysteines in the C-terminal SKTPCX(2–3)C motif
form a disulfide bridge
To address a possible role for the additional pair of cys-
teines (Cys-74 and Cys-78) from the SKTPCX(2–3)C motif
in disulfide formation, we quantified the free thiols (–SH)
in RFd2, under different conditions, using the DTNB assay
(Fig. 3). The protein contains a total of four cysteine res-
idues, two of which are involved in the coordination of the
[2Fe–2S] Rieske cluster (Cys-29 and Cys-50). The as-
prepared protein was found to contain no free thiols (less
than 0.1 SH mol-1), which shows that under these condi-
tions cysteines are unavailable to the DTNB reagent
(Fig. 3, scheme 1). At the other extreme, in a preparation
in which RFd2 was unfolded under reducing conditions and
cluster disassembly was further promoted by the presence
of EDTA, a total of 3.5 ± 0.3 SH mol-1 was quantified.
This corresponds to all cysteines in the protein becoming
available to the DTNB reagent (Fig. 3, scheme 4). On the
other hand, under the same denaturing conditions, if the
reductant is omitted, only 1.6 ± 0.2 SH mol-1 is quanti-
fied. The result is that under these conditions the cluster-
binding cysteines become available, whereas Cys-74 and
Cys-78 are not, thus confirming that they are involved in a
disulfide (Fig. 3, scheme 3). Additional control experi-
ments were carried out in which the cluster-binding cys-
teines and those from the SKTPCX(2–3)C motif were
selectively reduced. This was possible since we have
observed that incubation of RFd2 with 5 mM TCEP is
enough to reduce the disulfide bond (1.5 ± 0.2 SH mol-1;
Fig. 3, scheme 2) without reducing the Fe–S cluster, as the
visible absorption spectrum remains unchanged even after
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Fig. 2 Spectroscopic analysis of the Rieske cluster. a EPR spectrum
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5 h of incubation (Fig. S4). This provides a tool to generate
a protein form in which this disulfide is selectively broken
(RFd2SH). In summary, the cysteines within the C-terminal
SKTPCX(2–3)C motif are involved in a disulfide bridge,
which is novel within the Rieske fold. The other types of
disulfides known in Rieske proteins are discussed further
later, and are found in respiratory Rieske domains, namely,
on the prototypic complex III domains [17] and on the
SoxF protein from S. acidocaldarius [5, 30].
The Rieske fold and secondary structure
are not disrupted upon disulfide reduction
To fully characterize the role of the redox status of the
disulfide bridge in the folding and the conformation of
RFd2, we carried out a structural analysis using biophysical
methods. CD spectroscopy was inadequate for such a study
as the high content in the b-sheet of the Rieske fold
accounts for a relatively featureless spectrum in the far-UV
region, with a minimum around 200 nm, typical of proteins
with high amounts of random coil and no significant
amounts of a-helices, while showing the expected tertiary
structure fingerprint in the near-UV region (Fig. S5).
However, the multiple vibrational modes associated with b
structures produce highly informative infrared absorption
spectra. For the purpose, we used ATR FT-IR spectroscopy
to identify and estimate the relative amounts of each type
of secondary structure element in RFd2 preparations with
the disulfide in the oxidized (RFd2SS) and in the reduced
(RFd2SH) states. This was achieved by deconvoluting the
amide I band and carrying out assignments according to
established fingerprints. This analysis showed that the
spectra are nearly identical in both preparations (Fig. 4).
The secondary structure of the oxidized protein (Fig. 4,
plot A) is composed of 43% b-sheets, 25% random coil,
18% turns, and 8% a-helices, which is in a fair agreement
with the calculations made for the available Rieske struc-
tures. Around 6% of the secondary structure can be
accounted for as intermolecular b-sheet contacts, which are
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usually associated with aggregation. These are, however,
not significant in the overall structural content. The sec-
ondary structure changes brought about by disulfide
reduction (Fig. 4, plot B) are marginal and are within the
deconvolution error (Table S1). Therefore, reduction of the
disulfide does not result in partial unfolding or in a loss of
secondary structure.
The properties of the Rieske [2Fe–2S] cluster
are influenced by the redox status of the disulfide
Redox potentiometry was used to determine the oxidation–
reduction potential of the [2Fe–2S] Rieske cluster, using
visible absorption to monitor the reduction state of the
center during an anaerobic reductive titration using
dithionite. The process was reversible and a redox potential
of ?48 mV (pH 7) was determined (Fig. 5; open circles).
Taking advantage of the fact that the disulfide bond can be
broken while the Rieske cluster remains oxidized, we tes-
ted if the redox properties of the cluster would be influ-
enced by the status of the disulfide. We carried out a redox
titration on the disulfide-reduced RFd2 (RFdSH) and we
observed that the apparent redox potential of the Rieske
cluster increases by around 30 mV, to E0 = ?77 mV (pH
7) (Fig. 5; closed circles). These redox potentials are
intermediate between those of prototypic dioxygenase-type
Rieske ferredoxins (E0 & -180 mV, [31]) and respiratory
and photosynthetic Rieske domains (E0 & ?300 mV,
[17]), and this wide range has been suggested to result from
differences in solvent accessibility, hydrogen bonds, and
the spatial distribution of ionizable side chains around the
center among different types of Rieske proteins [29, 32].
The status of the disulfide bond also influences the redox
properties of the [2Fe–2S] cluster, as its reduction results in
a 30-mV increase in the potential. This effect may arise
from a change in the hydrogen-bond network around the
cluster as a result of disulfide reduction. Further investi-
gation of these factors in RFd2 will be possible when a
crystal structure becomes available, as the structural model
of the protein produced by I-TASSER [33] does not allow
such detailed analysis.
We also investigated the influence of the redox status of
the disulfide on the pKa values of the histidine ligands of
the [2Fe–2S] cluster, which can be estimated from the
analysis of the pH dependence of the visible CD spectrum
of the Rieske center, according to a well-established pro-
cedure [34]. We used the variation of the visible CD
spectra of RFd2, in the as-prepared form and in the pres-
ence of 5 mM TCEP, from pH 6.2 to 11.2 (Fig. S6). The
data could be fit with a single transition at pKa =
10.1 ± 0.2 (0 mM TCEP sample) or pKa = 8.9 ± 0.3
(5 mM TCEP sample), values which are intermediate
between the values reported for bc1 Rieske proteins [34]
and Rieske ferredoxins [32] in the oxidized [2Fe–2S]2?
state. The values determined probably correspond either to
a single or to an average of the two expected transitions
from the two protonatable histidines, which could not be
resolved. The decreased pKa in the disulfide-reduced state
reflects the double-protonation event following the disul-
fide cleavage and constitutes additional evidence for the
proximity of the intervening cysteines to the [2Fe–2S]
cluster, which is responsible for the dependence of the
cluster properties on the redox status of the disulfide. We
have confirmed that the spectral changes observed are due
to pH-dependent modifications at the [2Fe–2S] cluster and
not a result of a perturbation in the secondary structure or
folding, as the far-UV CD spectra in both assays were not
altered at the pH extremes (not shown). The presence of the
C-terminal His-tag could result in a shift of the pKa values
from those of the native, tagless protein. However, this
hypothetical perturbation is minimized because the N-ter-
minus and the [2Fe–2S] cluster are located on opposite
sides of the Rieske fold.
The stability of RFd2 is influenced by the redox state
of the disulfide
A role of the disulfide in the protein conformational stability
was investigated by performing chemical and thermal
unfolding experiments under conditions in which the
disulfide was formed and broken. We monitored the RFd2
folding using the intrinsic fluorescence of tyrosine residues
as a probe of the conformational state of the protein, as the
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protein contains no tryptophan. The chemical stability was
determined as a function of the concentration of GuHCl in
the disulfide oxidized and reduced states (Fig. 6a). From the
difference in the apparent midpoint denaturant concentra-
tions (Cm = 3.7 M for RFd2
SS and Cm = 3.0 M for
RFd2SH) it is clear that the disulfide increases the chemical
stability of the protein. We further explored an effect of this
bond on the thermal denaturation of the protein. As many
other proteins of hyperthermophilic origin, RFd2 unfolds
near or above the boiling point of water, as no transition is
observed when the temperature is increased from 25 to
95 C. To overcome this problem, a series of thermal
denaturation transitions were determined in the presence of
GuHCl at different concentrations, all below Cm. Under
these conditions, the protein becomes destabilized by the
presence of denaturant, but the majority of the molecules
are in the folded conformation, thus allowing the determi-
nation of an apparent midpoint denaturation temperature
(Tm) at different GuHCl concentrations, with the disulfide
intact and broken (Fig. 6b, c). Linearization plots can then
be used to extrapolate Tm in the absence of denaturant,
which is determined from the y-axis intercepts (Fig. 6d).
Using this strategy, we determined that RFd2 has Tm(H2O)
= 99 C, which is lowered to 91 C when the disulfide is
broken. The integrity of the Rieske [2Fe–2S] cluster was
also monitored upon thermal and chemical perturbation
using visible absorption spectroscopy and identical results
were obtained, indicating that protein unfolding and cluster
disintegration are intertwined events. Altogether, the
chemical and thermal unfolding data clearly show that the
disulfide involving Cys-74 and Cys-78 does have an
important contribution to structural stabilization.
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Conclusions
Rieske proteins are present in the three domains of life, and
are found to be involved in electron transfer processes
associated with different cellular processes, including res-
piration, photosynthesis, and dioxygenase systems [17, 35].
In recent years, studies on Rieske proteins from phyloge-
netically distant organisms, such as hyperthermophilic ar-
chaea [15], have elicited proteins with particular features
which enlarge the structural and functional diversity of
Rieske domains. In fact, there are proportionally fewer
Rieske proteins known in Archaea (approximately 100)
than in Eukarya (more than 450) or in Bacteria (more than
3,500), as currently listed in Pfam [36]. Here we reported
the characterization of a new subtype of soluble Rieske
ferredoxin of hyperthermophilic origin: essentially, this
protein contains all typical fingerprints of Rieske domains
in respect of the biophysical properties of its [2Fe–2S]
cluster. However, it harbors a disulfide bond at the C-ter-
minal region which has not yet been identified among the
Rieske family, whose redox status affects the stability of
the protein fold and of the Fe–S cluster, the redox prop-
erties of the latter, and the pH-associated properties of the
cluster ligands. Upon its disruption, a decrease in the
chemical (DCm = -0.7 M GuHCl) and thermal (DTm =
-9 C) stabilities, an increase in the redox potential of the
[2Fe–2S] center (DE0 = ?31 mV), and a decrease of the
pKa of the histidine ligands (1.2 units) are observed, likely
as a result of a rearrangement of the electrostatic, hydro-
gen-bonding, and covalent network around the metal
cluster environment.
Rieske proteins are believed to have the same structural
fold, which consists of two all-b subdomains: one conserved
small domain which has a rubredoxin-like fold, and a larger
domain which consists of six b-stands packed in either a
sandwich of two three-stranded sheets or a closed barrel
[17]. RFd2 typifies a new subtype of Rieske ferredoxins in
which the Rieske fold is decorated by a novel disulfide bond
which involves a cysteine pair located at the protein C-
terminus, within an SKTPCX(2–3)C motif. This motif
appears as an insertion within a region that corresponds to a
loop in dioxygenase Rieske proteins, and is present in five
other sequences from Archaea, which share a rather high
amino acid identity (approximately 37–52%) among them-
selves, but not against other types of Rieske proteins (less
than 15%). The disulfide bond now identified within this
family is a novel structural feature in the Rieske fold, and is
unrelated to the disulfides described in respiratory and
photosynthetic Rieske domains [17] and in the archaeal
respiratory-type SoxF [5], whose cysteines are intertwined
within the Fe–S binding motif (CXHXXC…CPCH), and the
one presumed to be present in sulredoxin [18].
The novel disulfide described within the conserved
Rieske fold may underlie a stabilization strategy comple-
mentary to others found in highly thermostable proteins,
which range from extensive hydrogen-bonding and salt-
bridge networks, to oligomerization, to reduction of loop
lengths, to the formation of tightly packed hydrophobic
cores. In fact, the destabilization observed upon disulfide
reduction is likely a consequence of the clipping effect
exerted by the bond, as the motif containing the disulfide is
inserted in a loop, which is also present in a shorter version
in the dioxygenase Rieske ferredoxins. Insertion of disul-
fide bonds to cross-link different parts of the polypeptide
chain with stabilizing effects is a frequent stabilizing
strategy of local structures, and in fact thermophiles are
predicted to contain a higher density of disulfide bonds
than mesophiles [37]. Apart from the examples within the
Rieske family discussed, other small Fe–S proteins also
have a disulfide bond included in the protein structure.
Those are the cases of the [3Fe–4S] ferredoxin II from
Desulfovibrio gigas [7], the [4Fe–4S] ferredoxin from
Thermotoga maritima, and the plant-type [2Fe–2S] ferre-
doxin from A. aeolicus [6]. However, with the exception of
the latter, the influence of disulfide on the protein stability
has not been systematically investigated.
Overall, the work reported here illustrates how minor
structural modifications modulate protein function and
stability, and contributes to an understanding of how rel-
atively simple folds may be fine-tuned. Further, the char-
acterization of a subtype of Rieske proteins present in
organisms rooting deeply in the tree of life is necessary to
understand the evolutionary aspects of this fold, which is
ubiquitous in nature.
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